Literature DB >> 26958724

Remarkable Mechanisms in Microbes to Resist Phage Infections.

Ron L Dy1, Corinna Richter1, George P C Salmond2, Peter C Fineran1.   

Abstract

Bacteriophages (phages) specifically infect bacteria and are the most abundant biological entities on Earth. The constant exposure to phage infection imposes a strong selective pressure on bacteria to develop viral resistance strategies that promote prokaryotic survival. Thus, this parasite-host relationship results in an evolutionary arms race of adaptation and counteradaptation between the interacting partners. The evolutionary outcome is a spectrum of remarkable strategies used by the bacteria and phages as they attempt to coexist. These approaches include adsorption inhibition, injection blocking, abortive infection, toxin-antitoxin, and CRISPR-Cas systems. In this review, we highlight the diverse and complementary antiphage systems in bacteria, as well as the evasion mechanisms used by phages to escape these resistance strategies.

Entities:  

Keywords:  Argonaute; CRISPR-Cas; abortive infection; bacteriophages; horizontal gene transfer; phage resistance; toxin-antitoxin

Year:  2014        PMID: 26958724     DOI: 10.1146/annurev-virology-031413-085500

Source DB:  PubMed          Journal:  Annu Rev Virol        ISSN: 2327-056X            Impact factor:   10.431


  76 in total

Review 1.  Impacts of type II toxin-antitoxin systems on cell physiology and environmental behavior in acetic acid bacteria.

Authors:  Kai Xia; Jiawen Ma; Xinle Liang
Journal:  Appl Microbiol Biotechnol       Date:  2021-05-22       Impact factor: 4.813

2.  Large-Scale Analyses of Human Microbiomes Reveal Thousands of Small, Novel Genes.

Authors:  Hila Sberro; Brayon J Fremin; Soumaya Zlitni; Fredrik Edfors; Nicholas Greenfield; Michael P Snyder; Georgios A Pavlopoulos; Nikos C Kyrpides; Ami S Bhatt
Journal:  Cell       Date:  2019-08-08       Impact factor: 41.582

3.  Different genetic and morphological outcomes for phages targeted by single or multiple CRISPR-Cas spacers.

Authors:  B N J Watson; R A Easingwood; B Tong; M Wolf; G P C Salmond; R H J Staals; M Bostina; P C Fineran
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

Review 4.  The impact of quorum sensing on the modulation of phage-host interactions.

Authors:  Josefina León-Félix; Claudia Villicaña
Journal:  J Bacteriol       Date:  2021-01-19       Impact factor: 3.490

Review 5.  Next-generation precision antimicrobials: towards personalized treatment of infectious diseases.

Authors:  Cesar de la Fuente-Nunez; Marcelo Dt Torres; Francisco Jm Mojica; Timothy K Lu
Journal:  Curr Opin Microbiol       Date:  2017-06-14       Impact factor: 7.934

Review 6.  Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation.

Authors:  Tina Y Liu; Jennifer A Doudna
Journal:  J Biol Chem       Date:  2020-08-14       Impact factor: 5.157

Review 7.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

8.  The Escherichia coli RnlA-RnlB toxin-antitoxin complex: production, characterization and crystallization.

Authors:  Gabriela Garcia-Rodriguez; Ariel Talavera Perez; Albert Konijnenberg; Frank Sobott; Jan Michiels; Remy Loris
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-01-01       Impact factor: 1.056

9.  Viral Satellites Exploit Phage Proteins to Escape Degradation of the Bacterial Host Chromosome.

Authors:  Amelia C McKitterick; Stephanie G Hays; Fatema-Tuz Johura; Munirul Alam; Kimberley D Seed
Journal:  Cell Host Microbe       Date:  2019-10-09       Impact factor: 21.023

10.  The Concerted Action of Two B3-Like Prophage Genes Excludes Superinfecting Bacteriophages by Blocking DNA Entry into Pseudomonas aeruginosa.

Authors:  Marco Antonio Carballo-Ontiveros; Adrián Cazares; Pablo Vinuesa; Luis Kameyama; Gabriel Guarneros
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.